Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Engage
Data as at: 23/04/2024
Fund manager benchmark
(Russell 2000 Biotech Growth) 50.000% + ( Nasdaq Biotechnology Index) 50.000%
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| RTW Biotech Opportunities | Share price total return | 8.6 | -35.7 | N/A | N/A |
| Biotechnology & Healthcare AIC sector | Share price total return | -1.4 | -20.8 | 3.2 | 127.7 |
| RTW Biotech Opportunities | NAV total return | 30.9 | 4.8 | N/A | N/A |
| Biotechnology & Healthcare AIC sector | NAV total return | 2.1 | -3.1 | 26.8 | 153.2 |
Scroll
Discrete annual performance (%)
| Return type | 23/04/19 - 20 | 23/04/20 - 21 | 23/04/21 - 22 | 23/04/22 - 23 | 23/04/23 - 24 | |
|---|---|---|---|---|---|---|
| RTW Biotech Opportunities | Share price total return | N/A | 52.6 | -33.9 | -10.5 | 8.6 |
| RTW Biotech Opportunities | NAV total return | N/A | 84.2 | -20.4 | 0.7 | 30.9 |
Scroll
Interactive graph
This chart defaults to 5y total return data, the time periods are fully customisable. Use the display button to choose to chart actual prices and NAVs. Click the tick-boxes to quickly add sector average or market index comparisons.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
